ArticleClinical kidney journal2017

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.

Sigrid Lundberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.